SAHPRA SAPC Regulatory Enforcement: Addressing ...

By João L. Carapinha

May 26, 2026

SAHPRA SAPC regulatory enforcement has intensified following the seizure of all GLP-1 and GIP injectable products at iDexis (Pty) Ltd trading as Sentra Pharmacy. An inspection on 11 May 2026 revealed the facility was manufacturing and distributing...
Impact of MDR Software Regulations on Medical Device Innovation
Key Milestone in GBA-PD Therapy Development Achieved with ACTIVATE Study Comp...
Innovative Insights into Menstrual Health Monitoring Through Wearable Technology
Advancements in Perioperative Bladder Cancer Therapy: A Promising New Regimen
Emergence of AI Healthcare Policy Amidst Fragmentation and Governance Challenges
Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment
CHMP Recommendations 2026: New Approvals and Implications for Health Economics
Clinical Trial Monitoring: Insights from Q1 2026 EU/EEA Report
Novartis Oncology Advancements: Key Trial Findings and Market Implications
EUDAMED Implementation 2026: Key Changes and National Adaptations
Baxfendy Hypertension Treatment: FDA Approves First-in-Class Aldosterone Synt...
TrumpRx.gov Expansion: Enhancing Medication Price Transparency and Competition